1. Market Research
  2. > Business Services
  3. > Research and Development Market Trends
  4. > Neuroinflammation - Pipeline Review, H1 2014

Neuroinflammation - Pipeline Review, H1 2014

  • May 2014
  • -
  • Global Markets Direct
  • -
  • 55 pages

Neuroinflammation - Pipeline Review, H1 2014

Summary

Global Markets Direct’s, ‘Neuroinflammation - Pipeline Review, H1 2014’, provides an overview of the Neuroinflammation’s therapeutic pipeline.

This report provides comprehensive information on the therapeutic development for Neuroinflammation, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Neuroinflammation and special features on late-stage and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global therapeutic landscape of Neuroinflammation
- The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities
- The report reviews key players involved in the therapeutics development for Neuroinflammation and enlists all their major and minor projects
- The report summarizes all the dormant and discontinued pipeline projects
- A review of the Neuroinflammation products under development by companies and universities/research institutes based on information derived from company and industry-specific sources
- Pipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stages
- A detailed assessment of monotherapy and combination therapy pipeline projects
- Coverage of the Neuroinflammation pipeline on the basis of target, MoA, route of administration and molecule type
- Latest news and deals relating related to pipeline products

Reasons to buy

- Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop strategic initiatives by understanding the focus areas of leading companies
- Identify and understand important and diverse types of therapeutics under development for Neuroinflammation
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Devise corrective measures for pipeline projects by understanding Neuroinflammation pipeline depth and focus of Indication therapeutics
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
- Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline

Table Of Contents

Neuroinflammation - Pipeline Review, H1 2014
Table of Contents
Table of Contents 2
List of Tables 5
List of Figures 5
Introduction 6
Global Markets Direct Report Coverage 6
Neuroinflammation Overview 7
Therapeutics Development 8
Pipeline Products for Neuroinflammation - Overview 8
Pipeline Products for Neuroinflammation - Comparative Analysis 9
Neuroinflammation - Therapeutics under Development by Companies 10
Neuroinflammation - Therapeutics under Investigation by Universities/Institutes 12
Neuroinflammation - Pipeline Products Glance 13
Clinical Stage Products 13
Early Stage Products 14
Neuroinflammation - Products under Development by Companies 15
Neuroinflammation - Products under Investigation by Universities/Institutes 16
Neuroinflammation - Companies Involved in Therapeutics Development 17
TxCell SA 17
to-BBB technologies BV 18
St. Charles Pharmaceuticals 19
VivaCell Biotechnology Espana S.L. 20
Neurotec Pharma SL 21
SciFluor Life Sciences, LLC 22
Creabilis SA 23
Neuroinflammation - Therapeutics Assessment 24
Assessment by Monotherapy Products 24
Assessment by Target 25
Assessment by Mechanism of Action 27
Assessment by Route of Administration 29
Assessment by Molecule Type 31
Drug Profiles 33
2B3-201 - Drug Profile 33
Product Description 33
Mechanism of Action 33
RandD Progress 33
Evasin-3 - Drug Profile 35
Product Description 35
Mechanism of Action 35
RandD Progress 35
diazoxide - Drug Profile 37
Product Description 37
Mechanism of Action 37
RandD Progress 37
NT-KO-009 - Drug Profile 39
Product Description 39
Mechanism of Action 39
RandD Progress 39
NT-KO-012 - Drug Profile 40
Product Description 40
Mechanism of Action 40
RandD Progress 40
NT-CC-017 - Drug Profile 41
Product Description 41
Mechanism of Action 41
RandD Progress 41
VCE-003 - Drug Profile 42
Product Description 42
Mechanism of Action 42
RandD Progress 42
Antibody for Inflammation - Drug Profile 43
Product Description 43
Mechanism of Action 43
RandD Progress 43
artemisinin - Drug Profile 44
Product Description 44
Mechanism of Action 44
RandD Progress 44
5-Methylthiazole Analogs - Drug Profile 45
Product Description 45
Mechanism of Action 45
RandD Progress 45
FP7 Project - Drug Profile 46
Product Description 46
Mechanism of Action 46
RandD Progress 46
Small Molecule for Inflammation - Drug Profile 47
Product Description 47
Mechanism of Action 47
RandD Progress 47
Drugs to Target Deubiquitinating Enzymes for Neuroinflammation - Drug Profile 48
Product Description 48
Mechanism of Action 48
RandD Progress 48
Small Molecule For Neuroinflammation - Drug Profile 49
Product Description 49
Mechanism of Action 49
RandD Progress 49
Myelin T-reg - Drug Profile 50
Product Description 50
Mechanism of Action 50
RandD Progress 50
Drugs to Inhibit 5-Lipoxygenase for Pain and Neuroinflammation - Drug Profile 51
Product Description 51
Mechanism of Action 51
RandD Progress 51
Neuroinflammation - Recent Pipeline Updates 52
Neuroinflammation - Dormant Projects 53
Appendix 54
Methodology 54
Coverage 54
Secondary Research 54
Primary Research 54
Expert Panel Validation 54
Contact Us 55
Disclaimer 55

List of Tables

Number of Products under Development for Neuroinflammation, H1 2014 8
Number of Products under Development for Neuroinflammation - Comparative Analysis, H1 2014 9
Number of Products under Development by Companies, H1 2014 11
Number of Products under Investigation by Universities/Institutes, H1 2014 12
Comparative Analysis by Clinical Stage Development, H1 2014 13
Comparative Analysis by Early Stage Development, H1 2014 14
Products under Development by Companies, H1 2014 15
Products under Investigation by Universities/Institutes, H1 2014 16
Neuroinflammation - Pipeline by TxCell SA, H1 2014 17
Neuroinflammation - Pipeline by to-BBB technologies BV, H1 2014 18
Neuroinflammation - Pipeline by St. Charles Pharmaceuticals, H1 2014 19
Neuroinflammation - Pipeline by VivaCell Biotechnology Espana S.L., H1 2014 20
Neuroinflammation - Pipeline by Neurotec Pharma SL, H1 2014 21
Neuroinflammation - Pipeline by SciFluor Life Sciences, LLC, H1 2014 22
Neuroinflammation - Pipeline by Creabilis SA, H1 2014 23
Assessment by Monotherapy Products, H1 2014 24
Number of Products by Stage and Target, H1 2014 26
Number of Products by Stage and Mechanism of Action, H1 2014 28
Number of Products by Stage and Route of Administration, H1 2014 30
Number of Products by Stage and Molecule Type, H1 2014 32
Neuroinflammation Therapeutics - Recent Pipeline Updates, H1 2014 52
Neuroinflammation - Dormant Projects, H1 2014 53

List of Figures

Number of Products under Development for Neuroinflammation, H1 2014 8
Number of Products under Development for Neuroinflammation - Comparative Analysis, H1 2014 9
Number of Products under Development by Companies, H1 2014 10
Comparative Analysis by Early Stage Products, H1 2014 14
Assessment by Monotherapy Products, H1 2014 24
Number of Products by Top 10 Target, H1 2014 25
Number of Products by Stage and Top 10 Target, H1 2014 26
Number of Products by Top 10 Mechanism of Action, H1 2014 27
Number of Products by Stage and Top 10 Mechanism of Action, H1 2014 28
Number of Products by Top 10 Route of Administration, H1 2014 29
Number of Products by Stage and Top 10 Route of Administration, H1 2014 30
Number of Products by Top 10 Molecule Type, H1 2014 31
Number of Products by Stage and Top 10 Molecule Type, H1 2014 32

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Scientific Research and Development (R&D) in Physics, Engineering, Telecommunications and Computers Industry (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts: NAIC 541712

Scientific Research and Development (R&D) in Physics, Engineering, Telecommunications and Computers Industry (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts: NAIC 541712

  • $ 1995
  • Industry report
  • November 2016
  • by Plunkett Research

Scientific Research and Development (R&D) in Physics, Engineering, Telecommunications and Computers Industry (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2023, NAIC ...

Specialized Design Services Global Market Analytics 2016

Specialized Design Services Global Market Analytics 2016

  • $ 1500
  • Industry report
  • November 2016
  • by TBRC Business Research

Specialized design services comprise companies that are involved in planning, designing and administering projects as per client needs and specifications. The specialized design services market does not ...

Scientific Research And Development Services Global Market Analytics 2016

Scientific Research And Development Services Global Market Analytics 2016

  • $ 1500
  • Industry report
  • November 2016
  • by TBRC Business Research

The scientific research and development services industry comprises establishments engaged in research and experimental development on a contract, consultancy or outsourced basis in the areas such as biotechnology, ...


ref:plp2014

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.